4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-16-145418
CIK 0001505512operating
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:02 PM ET
Size
5.4 KB
Accession
0001209191-16-145418
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-10-05+186,640→ 186,640 totalExercise: $3.52Exp: 2026-10-04→ Common Stock (186,640 underlying)
Footnotes (1)
- [F1]25% of the shares vest on October 5, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on October 5, 2021.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:02 PM ET
- Size
- 5.4 KB